Adverse Event Reporting & SAE Management

Digital Tools and Automation to Streamline Special Interest AEs & AESIs Digital Tools and Automation to Streamline Special Interest AEs & AESIs In the realm of clinical research, particularly concerning eCRF clinical trials, the accurate management and reporting of adverse events (AEs) and special interest adverse events (AESIs) is paramount. Special interest AEs and AESIs…

Read More “Digital Tools and Automation to Streamline Special Interest AEs & AESIs” »

Aligning Special Interest AEs & AESIs With GCP, ICH E2A–E2F and Local Regulations In the realm of clinical trials, the accurate reporting and management of adverse events (AEs) and adverse events of special interest (AESIs) is paramount. This necessity stems not only from regulatory demands but also from the intrinsic need for patient safety and…

Read More “Aligning Special Interest AEs & AESIs With GCP, ICH E2A–E2F and Local Regulations” »

Common Pitfalls in Special Interest AEs & AESIs—and How to Avoid Regulatory Findings Understanding Special Interest Adverse Events (AEs) and Adverse Events of Special Interest (AESIs) Adverse events (AEs) are any undesirable experiences associated with the use of a medical product in a patient. The categorization as either a general AE or a special interest…

Read More “Common Pitfalls in Special Interest AEs & AESIs—and How to Avoid Regulatory Findings” »

Case Studies: Special Interest AEs & AESIs That Strengthened Safety Oversight In the realm of clinical trials, particularly in medidata clinical trials, safety oversight is paramount. The evolution of adverse event (AE) reporting and management has become increasingly intricate, with a particular focus on special interest AEs (SIAEs) and adverse events of special interest (AESIs)….

Read More “Case Studies: Special Interest AEs & AESIs That Strengthened Safety Oversight” »

KRIs, KPIs and Dashboards to Monitor Special Interest AEs & AESIs Across Portfolios In the context of clinical trials, effective monitoring of Adverse Events (AEs) and Adverse Events of Special Interest (AESIs) is crucial for ensuring patient safety and regulatory compliance. In this step-by-step tutorial, we will explore the essential components of establishing Key Risk…

Read More “KRIs, KPIs and Dashboards to Monitor Special Interest AEs & AESIs Across Portfolios” »

Inspection-Ready Documentation Standards for Special Interest AEs & AESIs Inspection-Ready Documentation Standards for Special Interest AEs & AESIs In the realm of clinical research, particularly in precision medicine clinical trials, robust documentation standards for reporting special interest adverse events (AEs) and adverse events of special interest (AESIs) are crucial. These standards ensure compliance with regulatory…

Read More “Inspection-Ready Documentation Standards for Special Interest AEs & AESIs” »

Training Investigators and Sites to Execute Special Interest AEs & AESIs Reliably Training Investigators and Sites to Execute Special Interest AEs & AESIs Reliably In the realm of clinical trials, especially in oncology clinical research, understanding and addressing adverse events (AEs) and special interest adverse events of special interests (AESIs) is crucial for maintaining the…

Read More “Training Investigators and Sites to Execute Special Interest AEs & AESIs Reliably” »

Vendor and Partner Oversight Considerations in Special Interest AEs & AESIs Vendor and Partner Oversight Considerations in Special Interest AEs & AESIs In the clinical research landscape, the management of Adverse Events (AEs) and Serious Adverse Events (SAEs) is crucial to ensuring patient safety and data integrity. As clinical trials become increasingly complex, particularly in…

Read More “Vendor and Partner Oversight Considerations in Special Interest AEs & AESIs” »

Integrating Special Interest AEs & AESIs With DSURs, PBRERs and Risk Management Plans In the realm of clinical research, ensuring the safety and efficacy of investigational drugs is paramount. Within this framework, the monitoring of adverse events (AEs) and serious adverse events (SAEs) holds critical importance. This article focuses on the integration of Special Interest…

Read More “Integrating Special Interest AEs & AESIs With DSURs, PBRERs and Risk Management Plans” »

Future Trends: AI, Automation and Real-World Data in Special Interest AEs & AESIs Future Trends: AI, Automation and Real-World Data in Special Interest AEs & AESIs As the landscape of clinical trials evolves, the management of adverse events (AEs) and adverse events of special interest (AESIs) becomes increasingly vital. This tutorial explores the future trends…

Read More “Future Trends: AI, Automation and Real-World Data in Special Interest AEs & AESIs” »